James Edgemond - Nov 7, 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
CFO AND TREASURER
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Nov 7, 2022
Transactions value $
-$1,487,706
Form type
4
Date filed
11/9/2022, 03:31 PM
Next filing
May 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $261K +5K +361.27% $52.12 6.38K Nov 7, 2022 Direct F1, F2
transaction UTHR Common Stock Disposed to Issuer -$1.33M -5K -78.32% $266.80 1.38K Nov 7, 2022 Direct F1
transaction UTHR Common Stock Options Exercise $229K +2.41K +174.21% $94.96 3.8K Nov 7, 2022 Direct F1
transaction UTHR Common Stock Disposed to Issuer -$643K -2.41K -63.53% $266.80 1.38K Nov 7, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -5K -100% $0.00* 0 Nov 7, 2022 Share Tracking Award 5K $52.12 Direct F1
transaction UTHR Share Tracking Award Options Exercise $0 -2.41K -100% $0.00* 0 Nov 7, 2022 Share Tracking Award 2.41K $94.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Includes 23 shares acquired on September 4, 2019, 297 shares acquired on March 4, 2020, 156 shares acquired on March 4, 2021, 58 shares acquired on September 3, 2021, 97 shares acquired on March 4, 2022 and 26 shares acquired on September 2, 2022, under the United Therapeutics Corporation Employee Stock Purchase Plan.